Research suggests that in cardiovascular diseases, BCAA metabolism is disrupted due to downregulation of Krüppel-like factor 15 (KLF15), mediated by TAK1 and p38 MAPK signaling (28, 29). This evidence concerns the gene KLF15 and cardiovascular disorder.